Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Thomas R. Staab II currently holds 14,295 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas R. Staab II has been a net seller of BCRX stock. They have purchased $8.7K and sold $2.4M worth of shares.
Thomas R. Staab II's most recent insider trade was on Mar 19, 2026, when they sold 5,500 shares at $0.00 per share.
Thomas R. Staab II serves as Executive at BIOCRYST PHARMACEUTICALS INC (BCRX). They have executed 149 insider transactions totaling $2.4M over their tenure at the company.
Thomas R. Staab II holds the position of Executive at BIOCRYST PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Thomas R. Staab II has shown a selling trading pattern, with $8.7K in total purchases and $2.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Thomas R. Staab II was on Nov 8, 2018, when they sold $89.9K worth of BCRX shares. This transaction involved 11,113 shares at $8.09 per share.
Thomas R. Staab II currently owns 14,295 shares of BIOCRYST PHARMACEUTICALS INC (BCRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Thomas R. Staab II's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Thomas R. Staab II has 149 Form 4 filings on record as an insider at BIOCRYST PHARMACEUTICALS INC.
Set alerts for Thomas R. Staab II and 40,000+ other insiders.